Literature DB >> 12187061

Stroke and pediatric human immunodeficiency virus infection. Case report and review of the literature.

Prithvi Narayan1, Owen B Samuels, Daniel L Barrow.   

Abstract

Stroke is an uncommon complication in pediatric patients with acquired immunodeficiency syndrome (AIDS). However, with the increasing life span of this patient population, more cases of stroke are being reported. We report the case of a 13-year-old girl with a known history of AIDS who presented with new-onset seizures and right hemiparesis. Serial imaging studies revealed progressive occlusion of the left middle cerebral artery and both anterior cerebral arteries with development of collateral circulation. The workup for other etiologies of stroke was negative. This nonatherosclerotic occlusive disease is most likely secondary to vasculopathy caused by the human immunodeficiency virus (HIV). HIV infection should be included in the differential diagnosis of children who present with seizures, mental status change or focal neurological deficits. Treatment options are limited. The different prognoses associated with the etiologies of stroke in this patient population mandate a careful and thorough evaluation. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12187061     DOI: 10.1159/000064395

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  3 in total

1.  Treatment and prevention of cerebrovascular disorders in children.

Authors:  John Kylan Lynch; Steven Pavlakis; Gabrielle Deveber
Journal:  Curr Treat Options Neurol       Date:  2005-11       Impact factor: 3.598

2.  Stroke in a child with SARS-CoV-2 infection: A case report.

Authors:  Bkhtiar Khosravi; Borhan Moradvaesi; Masomeh Abedini; Shirin Behzadi; Awat Karimi
Journal:  eNeurologicalSci       Date:  2021-04-28

Review 3.  Infectious Agents and Stroke: A Systematic Review.

Authors:  Alia Saberi; Shahin Akhondzadeh; Samira Kazemi; Samaneh Kazemi
Journal:  Basic Clin Neurosci       Date:  2021-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.